Cardiac Fibrosis: Clinical Trials

10 trials for Cardiac Fibrosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 active not recruiting, 1 recruiting, 1 suspended. 2 Not applicable, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Recruiting 1, Suspended 1
Phase 21Terminated 1
Phase 41Active not recruiting 1

Follow Cardiac Fibrosis: new trials by email Literature Review of Cardiac Fibrosis trials Research Report on Cardiac Fibrosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Genetic Polymorphism on the Clinical Outcome to SGLT2 Inhibitors in Heart Failure Patients
SGLT2 inhibitor (Dapagliflozin 10mg) - Heart Failure - NYHA II - IV, Cardiac Fibrosis
Active not recruitingAin Shams University2002023-11-222025-03-30
The Effects of Inositol on Glucose Metabolism in Patients With Metabolic Syndrome at Risk of Cardiac Fibrosis
Inositol and alpha-lactalbumin - Metabolic Syndrome, Cardiac Fibrosis
Not applicableSuspendedLo.Li.Pharma s.r.l302022-12-232025-12-30
Metformin Use in Cardiac Fibrosis in PAI-1 Deficiency
Metformin Extended Release Oral Tablet - Plasminogen Activator Inhibitor-1 Deficiency, Cardiac Fibrosis
Phase 4Active not recruitingIndiana Hemophilia &Thrombosis Center, Inc.152022-10-102024-11-06
Immune Correlates of Cardiac Structure and Function
Cardiac MRI - Perinatal HIV Infection, Cardiac Fibrosis
CompletedDuke University402022-05-092024-03-21
Cardiovascular Fibrosis in Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis, Cardiac Fibrosis
CompletedSan Gerardo Hospital1002019-10-212022-10-26
Early MRI Detection of Myocardial Deterioration as a Preventive, Disease Staging, and Prognostic Biomarker in Insulin Resistance
Cardiomyopathies, Insulin Resistance
CompletedStanford University392015-01-152023-03-24
Characterization of Heart Failure With Preserved Ejection Fraction
cMR, biomarker - Heart Failure, Preserved Ejection Fraction, Cardiac Fibrosis
Not applicableRecruitingCliniques universitaires Saint-Luc- Université Catholique de Louvain5002014-12-042024-02-05
Pilot Study of Cardiac MR in Patients With Muscular Dystrophy
Muscular Dystrophies, Cardiac Fibrosis
CompletedChildren's National Research Institute602014-01-012024-12-11
Effects of Pycnogenol on Cardiac Fibrosis and Diastolic Dysfunction in Aged Hypertensive Subjects
Pycnogenol, Placebo - Cardiac Fibrosis, Diastolic Dysfunction
Phase 2TerminatedUniversity of Arizona92009-07-012013-12-17
Circulating P3NP and Cardiovascular Events in Hemodialysis Patients
Cardiovascular Events, Cardiac Fibrosis
CompletedToujinkai Hospital2442005-01-012018-01-08

Narrower conditions

Cardiomyopathies (1)  ·  Diabetes Mellitus (1)  ·  Genetic Diseases, Inborn (1)  ·  Heart Failure, Diastolic (1)  ·  Hypertension (1)  ·  Idiopathic Pulmonary Fibrosis (1)  ·  Insulin Resistance (1)  ·  Metabolic Syndrome (1)  ·  Muscular Dystrophies (1)  ·  Musculoskeletal Diseases (1)  ·  Plasminogen Activator Inhibitor-1 Deficiency (1)

Broader conditions

Cardiovascular Diseases (3)  ·  Glucose Metabolism Disorders (2)  ·  Heart Diseases (2)  ·  Hyperinsulinism (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Endocrine System Diseases (1)  ·  Heart Failure (1)  ·  Insulin Resistance (1)  ·  Lung Diseases (1)  ·  Lung Diseases, Interstitial (1)  ·  Muscular Diseases (1)  ·  Muscular Disorders, Atrophic (1)  ·  Nervous System Diseases (1)

Interventions

Biomarkers (1)  ·  Inositol (1)  ·  Lactalbumin (1)  ·  Metformin (1)  ·  Sodium-Glucose Transporter 2 Inhibitors (1)  ·  dapagliflozin (1)  ·  pycnogenols (1)

Sponsors

Ain Shams University (1)  ·  Children's National Research Institute (1)  ·  Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1)  ·  Duke University (1)  ·  Indiana Hemophilia &Thrombosis Center, Inc. (1)  ·  Lo.Li.Pharma s.r.l (1)  ·  San Gerardo Hospital (1)  ·  Stanford University (1)  ·  Toujinkai Hospital (1)  ·  University of Arizona (1)

Countries

United States (5)  ·  Italy (2)  ·  Belgium (1)  ·  Egypt (1)  ·  Japan (1)

Top investigators

Abha Khandelwal, MD (1)  ·  Amy D Shapiro, MD (1)  ·  Anne Catherine Pouleur (1)  ·  Bassem Zarif, MD (1)  ·  Christopher Spurney, MD (1)  ·  Claudio Ferri, MD (1)  ·  Davide Grassi, MD (1)  ·  Gerald Bloomfield, MD (1)  ·  Magdalena Lewandowska, MD (1)  ·  Masato Nishimura, MD (1)  ·  Paola Faverio, MD (1)  ·  Rajesh Dash, MD, PhD (1)  ·  Ronald R Watson, PhD (1)  ·  Sweta Gupta, MD (1)

Results publications

PMID 30086783, PMID 39077419, PMID 40121452, PMID 41495328

NIH funding

R56HL152803 (1)